How It Works Our Physicians Conditions Consultation Options For Physicians Patient Education Screening Guidelines FAQ Start Case Review
EXPERTISE

Conditions Covered

Our board-certified specialists provide expert reviews across a wide spectrum of oncological and hematological diagnoses.

Solid Tumors

  • Breast Cancer
  • Lung Cancer (NSCLC & SCLC)
  • Colorectal Cancer
  • Prostate Cancer
  • Pancreatic Cancer
  • Gastric & Esophageal Cancer
  • Ovarian Cancer
  • Uterine/Endometrial Cancer
  • Cervical Cancer
  • Kidney (Renal Cell) Cancer
  • Bladder Cancer
  • Melanoma
  • Head and Neck Cancers
  • Thyroid Cancer
  • Sarcomas (Bone & Soft Tissue)
  • Brain Tumors (Glioblastoma, etc.)
  • Liver Cancer (HCC)
  • Biliary Tract Cancers

Hematologic Malignancies

  • Non-Hodgkin Lymphoma (NHL)
  • Hodgkin Lymphoma
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myeloid Leukemia (CML)
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)

Genetic & Hereditary Syndromes

  • BRCA1/BRCA2 Mutations
  • Lynch Syndrome
  • Li-Fraumeni Syndrome
  • Familial Adenomatous Polyposis (FAP)
  • Other Hereditary Cancer Predispositions

Benign Hematology

  • Iron Deficiency Anemia
  • Anemia of Chronic Disease
  • Hemolytic Anemias (Autoimmune, Hereditary)
  • Sickle Cell Disease & Hemoglobinopathies
  • Thalassemia
  • Immune Thrombocytopenia (ITP)
  • Thrombotic Thrombocytopenic Purpura (TTP)
  • Coagulopathies (Factor Deficiencies, Hemophilia)
  • Thrombophilia & Hypercoagulable States
  • Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE)
  • Antiphospholipid Syndrome (APS)
  • Management of Oral Anticoagulants (Warfarin, DOACs)
  • Perioperative Anticoagulation Management
  • Heparin-Induced Thrombocytopenia (HIT)
  • Unexplained Cytopenias & Bone Marrow Evaluation

Genomic Testing Review

Modern oncology relies heavily on understanding the specific genetic mutations driving a tumor. Our specialists are highly experienced in interpreting complex Next-Generation Sequencing (NGS) reports to identify targeted therapy options and clinical trial eligibility.

FoundationOne® Tempus Caris Life Sciences® Guardant360® Invitae Myriad

Don't see your specific diagnosis listed? We likely still cover it.

Contact Us to Inquire